Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 https://altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT - Oct 16th, 2021 1:35 am
Altimmune to Present at Upcoming H.C. Wainwright Investor Conferences October 12-13, 2021 - Oct 6th, 2021 8:01 pm
Altimmune Announces Initiation of 12-week Phase 1b Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease - Oct 4th, 2021 11:00 am
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Altimmune, Inc. (ALT) Investigation - Oct 1st, 2021 5:00 pm
Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021 - Sep 29th, 2021 10:15 pm
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers - Sep 28th, 2021 11:01 am
Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021 - Sep 27th, 2021 8:01 pm
Shareholders Will Likely Find Altimmune, Inc.'s (NASDAQ:ALT) CEO Compensation Acceptable - Sep 17th, 2021 10:12 am
Altimmune to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 - Sep 7th, 2021 8:01 pm
Do Institutions Own Altimmune, Inc. (NASDAQ:ALT) Shares? - Sep 2nd, 2021 10:21 am
Are Options Traders Betting on a Big Move in Altimmune (ALT) Stock? - Aug 27th, 2021 12:31 pm
Altimmune Announces Second Quarter 2021 Financial Results and Provides a Corporate Update - Aug 10th, 2021 8:01 pm
Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021 - Aug 4th, 2021 8:01 pm
Will Altimmune, Inc. (ALT) Report Negative Q2 Earnings? What You Should Know - Aug 3rd, 2021 7:00 pm
Altimmune (NASDAQ:ALT) Is In A Good Position To Deliver On Growth Plans - Jul 4th, 2021 7:39 am
Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial - Jun 29th, 2021 8:01 pm
Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock? - Jun 17th, 2021 5:15 am
Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese Volunteers - Jun 16th, 2021 11:00 am
Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference - May 27th, 2021 11:00 am
Altimmune Demonstrates Strong Neutralization of South African Variant in Preclinical Study of Intranasal AdCOVID™ - May 26th, 2021 11:00 am